Alembic Pharmaceuticals gets EIR for oncology formulation facility (F-2) at Panelav

06 May 2024 Evaluate

Alembic Pharmaceuticals has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at its Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav from February 28, 2024 to March 8, 2024. With this, for all its USFDA facilities, EIRs are in place.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Alembic Pharma Share Price

1043.95 5.75 (0.55%)
22-Nov-2024 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.35
Dr. Reddys Lab 1207.90
Cipla 1485.60
Lupin 2057.60
Zydus Lifesciences 945.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.